Projects
The pharmaceutical projects listed in this section are those that are announced from time to time around the world
Merck Invests €70 Million to Expand ADC Manufacturing for Cancer Therapies in the U.S.
Merck Company has announced 70 million to expand its ADC manufacturing capabilities in the USA This expansion will significantly increase capacity, tripling the current levels, and strengthen the companys contract development and manufacturing organization
Piramal Pharma Invests $80 Million to Expand Sterile Injectable Facility in Kentucky
Piramal Pharma Solutions PPS is investing $80M to expand its Lexington, Kentucky facility This site specializes in sterile injectable drug products, including compounding, liquid filling, and lyophilization The expansion will support PPSs ADCelerate
AstraZeneca Invests $3.5 Billion to Expand R&D and Manufacturing in the U.S
AstraZeneca has unveiled plans for a $35 billion capital investment in the United States to enhance its research and manufacturing capabilities This initiative includes $2 billion allocated to new projects, which are set to generate over a thousand highskilled jobs, bolstering
Thermo Fisher Scientific to Expand Kentucky Clinical Research Facility with $47.8 Million Investment
Thermo Fisher Scientific Incs PPD clinical research business is embarking on a significant expansion of its central laboratory operations in Kentucky
Novo Nordisk to Invest $4.1 Billion in Expanding US Manufacturing Capacity
Novo Nordisk has announced a $41 billion USD approximately 27 billion Danish kroner investment to build a new fill and finishing manufacturing facility in Clayton, North Carolina
PCI's New Facility Expansion Begins with Installation of Sterile Fill-Finish and Lyophilization Line in $100 Million Capital Investment
The leading CDMO is currently installing key equipment for its latest sterile fillfinish facility, including twin lyophilizers and a stateoftheart largescale isolator filling line
Merck Invests Over €300M in Advanced Life Science Research Center in Germany
Merck is investing over 300 million in a new research center at its global headquarters in Darmstadt, Germany This Advanced Research Center will focus on developing solutions
£400 Million Investment by Almac Group to Boost Manufacturing and Peptide Production
The Almac Group has introduced two stateoftheart facilities at its Craigavon headquarters in Northern Ireland, pushing its global expansion investment to over 400 million $500 million
Novartis Invests $256 Million to Expand Singapore Biopharma Plant
In a significant move to enhance its global production capabilities, Novartis has announced a commitment of $256 million to expand its biopharma plant in Singapore
Pharmascience Expands CDMO Services with $120M Commercial Unit Investment in Canada
Pharmascience, Canadas leading pharmaceutical company, announces an expansion of its sterile injectable manufacturing facility at the Candiac site
